In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
The price of Lucid Diagnostics Inc (NASDAQ: LUCD) closed at $1.34 in the last session, down -9.46% from day before closing price of $1.48. In other words, the price has decreased by -$9.46 from its previous closing price. On the day, 0.6 million shares were traded.
Ratios:
We take a closer look at LUCD’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 1.11 and its Current Ratio is at 1.18. In the meantime, Its Debt-to-Equity ratio is 2.06 whereas as Long-Term Debt/Eq ratio is at 0.32.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Ascendiant Capital Markets on December 27, 2021, initiated with a Buy rating and assigned the stock a target price of $16.
On November 08, 2021, Needham started tracking the stock assigning a Buy rating and target price of $17.
On November 08, 2021, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $21.Cantor Fitzgerald initiated its Overweight rating on November 08, 2021, with a $21 target price.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 18.98.
Stock Price History:
Over the past 52 weeks, LUCD has reached a high of $1.63, while it has fallen to a 52-week low of $0.63. The 50-Day Moving Average of the stock is 30.62%, while the 200-Day Moving Average is calculated to be 49.76%.
Shares Statistics:
A total of 51.60M shares are outstanding, with a floating share count of 22.53M. Insiders hold about 62.03% of the company’s shares, while institutions hold 7.60% stake in the company.
